{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T05:02:43Z","timestamp":1695531763444},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Ricerca Clin. Lab."],"published-print":{"date-parts":[[1983,1]]},"DOI":"10.1007\/bf02904746","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T13:11:27Z","timestamp":1639487487000},"source":"Crossref","is-referenced-by-count":2,"title":["Antithrombin III concentrates in intensive care"],"prefix":"10.1007","volume":"13","author":[{"given":"Wolfgang","family":"Bernhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Nov\u00e1kov\u00e1-Banet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02904746_CR1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-0609.1968.tb00864.x","volume":"5","author":"U. Abildgaard","year":"1968","unstructured":"Abildgaard U.: Inhibitions of the thrombin-fibrinogen reactions by heparin in the absence of cofactor.\u2014Scand. J. Haemat.5, 432, 1968.","journal-title":"Scand. J. Haemat."},{"key":"BF02904746_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0609.1981.tb01369.x","volume":"25","author":"H. R. B\u00fcller","year":"1980","unstructured":"B\u00fcller H. R., Weenink A. H., Trefers P. E., Kahl\u00e9 L. H., Otten H. A., ten Cate J. W.: Severe antithrombin III deficiency in a patient with pre-ecampsia\u2014Scand. J. Haemat.25, 81, 1980.","journal-title":"Scand. J. Haemat."},{"key":"BF02904746_CR3","first-page":"550","volume-title":"Fibrinolyse, Thrombose, H\u00e4mostase","author":"R. Egbring","year":"1980","unstructured":"Egbring R., Menche B., Jacoby S.: Vergleichende Antithrombin III.-Bestimmung bei Patienten mit akuten Leuk\u00e4mien, Septik\u00e4mien, chronischen Lebererkrankungen, Malignomen und Thrombosen und\/oder Lungenembolien sowie vor und nach Antithrombin III-Konzentrat-Gabe. In:Deutsch E. R., Lechner K. (Eds): Fibrinolyse, Thrombose, H\u00e4mostase. Schattauer-Verlag, Stuttgart-New York, 1980; p. 550."},{"key":"BF02904746_CR4","first-page":"397","volume":"98","author":"M. Fischer","year":"1970","unstructured":"Fischer M.: Verhalten menschlicher Thrombininhibitoren (\u03b12-Makroglobulin und Antithrombin III) w\u00e4hrend und nach chirurgischen und gyn\u00e4kologisch-geburtshilflichen Eingriffen \u2014Folia haemat (Frankfurt)98, 397, 1970.","journal-title":"Folia haemat (Frankfurt)"},{"key":"BF02904746_CR5","first-page":"51","volume":"91","author":"A. Gassner","year":"1979","unstructured":"Gassner A., Pall H., Kleinberger G., Neumann E., Thaler E., Pichler M., Magometschnigg D., Lenzhofer R., Thaler H.: Verhauf und Intensivtherapie bei einem Fall vonMalaria tropica\u2014Wien. klin. Wschr.91, 51, 1979.","journal-title":"Wien. klin. Wschr."},{"key":"BF02904746_CR6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2106\/00004623-197961050-00002","volume":"61-A","author":"S. N. Gitel","year":"1979","unstructured":"Gitel S. N., Salvati E. A., Wessler S., Robinson H. J., Worth M. H.: The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis \u2014J. Bone Jt Surg.61-A, 653, 1979.","journal-title":"J. Bone Jt Surg."},{"key":"BF02904746_CR7","first-page":"297","volume":"33","author":"U. G\u00f6bel","year":"1980","unstructured":"G\u00f6bel U., J\u00fcrgens H., Kries V. R.: Gerinnungsdiagnostik in der Neonatalperiode mit Hilfe von chromogenen Peptiden\u2014Med. Lab.33, 297, 1980.","journal-title":"Med. Lab."},{"key":"BF02904746_CR8","first-page":"353","volume-title":"Proc. 1st Int. Symp on Tissue factor in, hemostasis of the coagulation-fibrinolysis system. Firenze, 1967","author":"N. Heimburger","year":"1967","unstructured":"Heimburger N.: On the proteinase inhibitors of human plasma with special reference to antithrombin. In: Proc. 1st Int. Symp on Tissue factor in, hemostasis of the coagulation-fibrinolysis system. Firenze, 1967. Unione Chimica Medicamenti. Torino, 1967; p. 353."},{"key":"BF02904746_CR9","first-page":"1","volume-title":"Proc. Int. Res. Conf. on Proteinase inhibitors. Munich, 1970","author":"N. Heimburger","year":"1971","unstructured":"Heimburger N., Haupt H., Schwick H. G.: Proteinase inhibitors of human plasma. In: Proc. Int. Res. Conf. on Proteinase inhibitors. Munich, 1970. Walter de Gruyter Verlag, Berlin-New York, 1971; p. 1."},{"key":"BF02904746_CR10","first-page":"37","volume-title":"Abstr. 2. Kongr. Thrombose und Blutgerinnung","author":"V. R. Kries","year":"1982","unstructured":"Kries V. R., J\u00fcrgens H., G\u00f6bel U.: Applikation und Dosierung der Antithrombin III-Behandlung im Kindesalter. In: Abstr. 2. Kongr. Thrombose und Blutgerinnung. Deutsche Arbeitsgemeinschaft f\u00fcr Blutgerinnungsforschung. M\u00fcnster, 1982; p. 37."},{"key":"BF02904746_CR11","first-page":"382","volume":"21","author":"H. G. Lasch","year":"1980","unstructured":"Lasch H. G., M\u00fcller-Berchaus G.: Verbrauchskoagulopathie-Heparinbehandlung? \u2014Internist (Berl.)21, 382, 1980.","journal-title":"Internist (Berl.)"},{"key":"BF02904746_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0049-3848(81)90070-0","volume":"22","author":"B. Laursen","year":"1981","unstructured":"Laursen B., Mertensen J. Z., Frost L., Hansen K. B.: Disseminated intravascular coagulation in hepatic failure treated with antithrombin III\u2014Thrombos. Res.22, 701, 1981.","journal-title":"Thrombos. Res."},{"key":"BF02904746_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1515\/bchm2.1959.317.1.64","volume":"317","author":"F. Markwardt","year":"1959","unstructured":"Markwardt F., Walsmann P.: Untersuchungen \u00fcber den Mechanismus der Antithrom-binwirkung des Heparins\u2014Hoppe-Seylers Z. physiol. Chem.317, 64, 1959.","journal-title":"Hoppe-Seylers Z. physiol. Chem."},{"key":"BF02904746_CR14","first-page":"223","volume":"86","author":"C. R. Pickhardt","year":"1980","unstructured":"Pickhardt C. R., Gr\u00f6schel G., Horn K., Rinkl H., Schramm W., Unterholzner H.: Plasmapherese an Hohlfasern in der Behandlung der thyreotoxischen Krise\u2014Verh. dtsch. Ges. inn. Med.86, 223, 1980.","journal-title":"Verh. dtsch. Ges. inn. Med."},{"key":"BF02904746_CR15","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1016\/S0021-9258(19)43472-8","volume":"248","author":"R. D. Rosenberg","year":"1973","unstructured":"Rosenberg R. D., Damm D. S.: The purification and mechanism of action of human antithrombin-heparin cofactor\u2014J. biol. Chem.248, 6490, 1973.","journal-title":"J. biol. Chem."},{"key":"BF02904746_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0049-3848(84)90034-3","volume":"21","author":"H. G. Schipper","year":"1981","unstructured":"Schipper H. G., Roos J., van der Meulen F., ten Cate J.: Antithrombin III deficiency in surgical intensive care patients\u2014Thrombos. Res.21, 73, 1981.","journal-title":"Thrombos. Res."},{"key":"BF02904746_CR17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1055\/s-2008-1070821","volume":"105","author":"W. Schramm","year":"1980","unstructured":"Schramm W.: Multitransfusion\u2014Pathophysiologie und praktische Konsequenzen\u2014Dtsch. med. Wschr.105, 1105, 1980.","journal-title":"Dtsch. med. Wschr."},{"key":"BF02904746_CR18","first-page":"1","volume":"21","author":"W. Schramm","year":"1981","unstructured":"Schramm W.: Antithrombin III-Mangel: Klinische Symptome und M\u00f6glichkeiten der Therapie \u2014Die gelben Hefte21, 1, 1981.","journal-title":"Die gelben Hefte"},{"key":"BF02904746_CR19","first-page":"491","volume-title":"Fibrinolyse, Thrombose, H\u00e4mostase","author":"W. Schramm","year":"1980","unstructured":"Schramm W., Marx R.: Zur Behandlung thrombophiler Diathesen\u2014Substitution mit Antithrombin III-Konzentrat. In:Deutsch E. R., Lechner K. (Eds), Fibrinolyse, Thrombose, H\u00e4mostase. Schattauer-Verlag, Stuttgart-New York, 1980; p. 491."},{"key":"BF02904746_CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/ajcp\/69.4.367","volume":"69","author":"W. Seecers","year":"1978","unstructured":"Seecers W.: Antithrombin III. Theory and clinical applications\u2014Amer. J. clin. Path.69, 367, 1978.","journal-title":"Amer. J. clin. Path."},{"key":"BF02904746_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1046\/j.1537-2995.1979.19580059816.x","volume":"19","author":"Y. Sultan","year":"1979","unstructured":"Sultan Y., Bussel A., Maisonneuve P., Poupeney M., Sitthy X., Gajdos P.: Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease. Transfusion (Philad.)19, 588, 1979.","journal-title":"Transfusion (Philad.)"},{"key":"BF02904746_CR22","first-page":"54","volume":"16","author":"E. Thaler","year":"1980","unstructured":"Thaler E., Kleinberger E.: Sepsis und Blutgerinnung\u2014Intensivmedizin16, 54, 1980.","journal-title":"Intensivmedizin"},{"key":"BF02904746_CR23","first-page":"7","volume":"21","author":"G. E. Vogel","year":"1981","unstructured":"Vogel G. E.: Leber und Antithrombin III\u2014Die gelben Hefte21, 7, 1981.","journal-title":"Die gelben Hefte"},{"key":"BF02904746_CR24","first-page":"471","volume-title":"Mikrozirkulation und Prostaglandinstoffwechsel","author":"G. E. Vogel","year":"1981","unstructured":"Vogel G. E., Clarmann V. M., Komm Ch., Oserdcrfer A.: Die Therapie mit Antithrombin III (ATIII) beim akuten Leberversagen (ALV). In:Bl\u00fcmel G., Haas S. (Eds): Mikrozirkulation und Prostaglandinstoffwechsel. Schattauer-Verlag, Stuttgart-New York, 1981; p. 471."}],"container-title":["La Ricerca in Clinica e in Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02904746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02904746\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02904746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T13:11:44Z","timestamp":1639487504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02904746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983,1]]}},"alternative-id":["BF02904746"],"URL":"https:\/\/doi.org\/10.1007\/bf02904746","relation":{},"ISSN":["0390-5748"],"issn-type":[{"value":"0390-5748","type":"print"}],"subject":[],"published":{"date-parts":[[1983,1]]},"article-number":"61"}}